Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Technology ID
TAB-4366

Methods for Single Cell Analysis of the Epigenome, Transcriptome, and Genome

E-Numbers
E-069-2017-0
Lead Inventors
Tosato, Giovanna
Co-Inventors
Ohnuki, Hidetaka
Applications
Diagnostics
Therapeutic Areas
Oncology
Development Stages
Discovery
Lead IC
NCI
ICs
NCI

There are currently no methodologies that allow for epigenome, genome and transcriptome analysis all in a single cell. In addition, there are currently no methodologies that permit repeating the results of these analyses on the same single cells.

Scientists at the National Cancer Institute (NCI) Laboratory of Cellular Oncology have developed a method for generating a “reusable” single cell by crosslinking cellular proteins and DNA to a polyacrylamide scaffold, thus preserving the proteins and genomic DNA in their location even after repeated experiments on the same cell. Given the reusability of the cell, each experiment can be repeated multiple times, and statistical analysis can be applied to validate the results from single cells.  Methods for detecting epigenetic changes using this methodology are also disclosed.  

Competitive Advantages:

  • The ability to “reuse” a single cell overcomes major issues that currently impair single cell analysis, such as analyzing multiple epigenetic modifications, lack of reproducibility controls, and statistical analysis

Commercial Applications:

  • Research Tool
  • Diagnostic Assays

 

Licensing Contacts